Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex
about
Immunotherapy of Childhood SarcomasRadioimmunotherapy of human tumoursBispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.GD2-targeted immunotherapy and radioimmunotherapyRetargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody.Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancersTheranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.Pretargeted Imaging and Therapy.The making of bispecific antibodiesAnti-GD2 immunotherapy for neuroblastoma.Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
P2860
Q26795369-79ED13CE-CE9D-4939-A8C2-F70B32F60D12Q28088825-78275B83-7E5E-40CE-9AB6-E5D559D4557FQ34548319-5C88BB47-21C9-4F24-91FD-9AFB581E5450Q34625339-DC5A7B22-6DC6-4F03-90B4-C40A88108760Q35152029-497C161B-182C-40AB-BBF0-08F8CC4FFA22Q36699195-C8345526-BA12-4937-9B85-9955875ED5EAQ36746466-49F79251-1A72-4C22-93FA-C6E296A057A4Q38400420-84EB4D58-645A-4B60-90D1-C23068E910A2Q38707896-78D31D1F-1B31-4A12-B148-01105C7A971EQ38722557-B24D3008-E629-467C-818A-3D1E2A6E5E63Q39421977-5332B2EC-77F2-43BA-859C-9BC7BE0D6193Q42323236-4E0A2390-E2EA-4E34-B465-72A707AC4C6FQ47554435-469E7D68-2EE2-47AA-8727-B73312ADA656Q49601103-4B26146D-C84D-406B-B505-5E5DC233F882Q59133661-D40ECFA4-B389-429F-9B9F-3C713EB08381
P2860
Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@ast
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@en
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@nl
type
label
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@ast
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@en
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@nl
prefLabel
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@ast
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@en
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@nl
P2093
P2860
P1476
Preclinical evaluation of mult ...... for GD2 and DOTA metal complex
@en
P2093
Hong-fen Guo
Nai-Kong Cheung
Pat B Zanzonico
Sarah M Cheal
P2860
P304
P356
10.1158/1535-7163.MCT-13-0933
P50
P577
2014-06-18T00:00:00Z